1:42 Panel start
2:56 Panelist introductions
15:00 How to get into venture
18:51 Getting in front of VCs
23:10 How early-stage funds source deals
25:12 How VCs start companies
30:14 Accelerators and incubators
31:29 What do late-stage funds look for?
33:07 What do early-stage funds look for?
34:33 What do VCs look for in a team?
37:39 How do VCs evaluate deals?
42:06 Advice for first-time scientific founders
43:52 Value of grit
46:25 How to handle feedback
49:33 How long does it take VCs to make an investment?
51:23 Interesting trends in biotech
52:07 Opportunities in CNS / neuro
55:37 Next-gen immuno-oncology
56:25 Getting to clinical proof of concept faster and cheaper
59:15 Precision medicine -- what it really means and why it matters
1:00:02 Programming organisms, new therapeutic modalities
1:00:42 Digital therapeutics -- need for evidence
1:02:45 What makes a great team?
1:07:38 Biotech VCs vs. angel investors
1:10:17 IP for early-stage companies
1:14:11 IP for late-stage companies
1:16:04 IP attorney's thoughts on startup IP
1:17:39 Valuing platforms vs products
1:23:31 The case for the entrepreneur
1:25:47 Lean startup principles applied to biotech
We offer a number of programs and products to the biotech community (with more to come!):
A free, selective 10-week program connecting Berkeley, Stanford and UCSF PhD students and postdocs with VCs and entrepreneurs to learn about starting companies
We'll be organizing more events for the Bay Area biopharma community, from happy hours to panel discussions
Our goal is to support the next generation of biopharma entrepreneurs. Let us know how we can help.